Agilent Technologies (A) Net Profit Margin: History & Chart

Agilent Technologies, Inc.(A)

Medical - Diagnostics & Research · Santa Clara, CA

$146.85-4.01 (-2.66%)

At close: Sep 8, 2026 (market close, ET)

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

18,000 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials

A Net Profit Margin Metrics

NET PROFIT MARGIN

19.53%

NET PROFIT MARGIN AVG TTM

19.47%

NET PROFIT MARGIN AVG 3Y

19.54%

NET PROFIT MARGIN AVG 5Y

18.64%

NET PROFIT MARGIN AVG 10Y

16.95%

NET PROFIT MARGIN AVG 15Y

15.66%

NET PROFIT MARGIN AVG 20Y

14.73%

CURRENT VS TTM AVG

+0.29%

CURRENT VS 3Y AVG

-0.03%

CURRENT VS 5Y AVG

+4.77%

CURRENT VS 10Y AVG

+15.19%

CURRENT VS 15Y AVG

+24.75%

CURRENT VS 20Y AVG

+32.56%

SECTOR MEDIAN · HEALTHCARE

8.98%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+117.48%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Agilent Technologies, Inc. (A)	$41.48B	19.53%	19.47%	19.54%	18.64%
IDEXX Laboratories, Inc. (IDXX)vs ›	$41.04B	25.03%	23.70%	22.66%	22.55%
IQVIA Holdings Inc. (IQV)vs ›	$42.67B	8.10%	8.63%	8.47%	7.22%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$42.81B	4.08%	-0.87%	-5.42%	-7.16%
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$34.80B	16.82%	-1.96%	-34.26%	-68.70%
Humana Inc. (HUM)vs ›	$48.40B	0.88%	0.97%	1.82%	2.53%
Alcon Inc. (ALC)vs ›	$33.71B	5.92%	9.84%	8.46%	5.10%
Becton, Dickinson and Company (BDX)vs ›	$49.35B	4.52%	8.06%	8.30%	8.27%
Edwards Lifesciences Corporation (EW)vs ›	$49.93B	15.43%	47.22%	37.68%	33.03%
ResMed Inc. (RMD)vs ›	$32.06B	26.94%	27.08%	24.30%	22.30%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Agilent Technologies, Inc. (A)

$41.48B

19.53%

19.47%

19.54%

18.64%

IDEXX Laboratories, Inc. (IDXX)vs ›

$41.04B

25.03%

23.70%

22.66%

22.55%

IQVIA Holdings Inc. (IQV)vs ›

$42.67B

8.10%

8.63%

8.47%

7.22%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$42.81B

4.08%

-0.87%

-5.42%

-7.16%

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$34.80B

16.82%

-1.96%

-34.26%

-68.70%

Humana Inc. (HUM)vs ›

$48.40B

0.88%

0.97%

1.82%

2.53%

Alcon Inc. (ALC)vs ›

$33.71B

5.92%

9.84%

8.46%

5.10%

Becton, Dickinson and Company (BDX)vs ›

$49.35B

4.52%

8.06%

8.30%

8.27%

Edwards Lifesciences Corporation (EW)vs ›

$49.93B

15.43%

47.22%

37.68%

33.03%

ResMed Inc. (RMD)vs ›

$32.06B

26.94%

27.08%

24.30%

22.30%

Net Profit Margin FAQ

What is the net profit margin for Agilent Technologies, Inc. (A)?

The net profit margin for A stock is 19.53%.

Is Agilent Technologies, Inc.'s net profit margin high or low?

The net profit margin of 19.53% is in line with its 5-year average of 18.64%, around the middle of its 5-year range (6.64%–28.14%).

What is the TTM average net profit margin for Agilent Technologies, Inc. (A)?

The TTM average net profit margin for A stock is 19.47%.

What is the 3Y average net profit margin for Agilent Technologies, Inc. (A)?

The 3Y average net profit margin for A stock is 19.54%.

What is the 5Y average net profit margin for Agilent Technologies, Inc. (A)?

The 5Y average net profit margin for A stock is 18.64%.

What is the 10Y average net profit margin for Agilent Technologies, Inc. (A)?

The 10Y average net profit margin for A stock is 16.95%.

What is the 15Y average net profit margin for Agilent Technologies, Inc. (A)?

The 15Y average net profit margin for A stock is 15.66%.

What is the 20Y average net profit margin for Agilent Technologies, Inc. (A)?

The 20Y average net profit margin for A stock is 14.73%.

DATE	NET PROFIT MARGIN
2026-07-31	19.28%
2026-04-30	18.47%
2026-01-31	16.96%
2025-10-31	23.32%
2025-07-31	19.33%
2025-04-30	12.89%
2025-01-31	18.92%
2024-10-31	20.63%
2024-07-31	17.87%
2024-04-30	19.58%
2024-01-31	20.99%
2023-10-31	28.14%
2023-07-31	6.64%
2023-04-30	17.59%
2023-01-31	20.05%
2022-10-31	19.90%
2022-07-31	19.15%
2022-04-30	17.05%
2022-01-31	16.91%
2021-10-31	26.63%
2021-07-31	16.65%
2021-04-30	14.16%
2021-01-31	18.60%
2020-10-31	14.97%
2020-07-31	15.78%
2020-04-30	8.16%
2020-01-31	14.52%
2019-10-31	14.19%
2019-07-31	14.99%
2019-04-30	14.70%
2019-01-31	39.25%
2018-10-31	15.07%
2018-07-31	19.62%
2018-04-30	17.00%
2018-01-31	-26.42%
2017-10-31	14.89%
2017-07-31	15.71%
2017-04-30	14.88%
2017-01-31	15.75%
2016-10-31	11.16%
2016-07-31	11.88%
2016-04-30	8.93%
2016-01-31	11.77%
2015-10-31	13.53%
2015-07-31	10.95%
2015-04-30	9.03%
2015-01-31	6.14%
2014-10-31	6.52%
2014-07-31	14.57%
2014-04-30	14.07%
2014-01-31	19.35%
2013-10-31	12.28%
2013-07-31	10.17%
2013-04-30	9.58%
2013-01-31	10.65%
2012-10-31	24.05%
2012-07-31	14.10%
2012-04-30	14.71%
2012-01-31	14.07%
2011-10-31	16.72%
2011-07-31	19.52%
2011-04-30	11.93%
2011-01-31	12.71%
2010-10-31	18.53%
2010-07-31	14.81%
2010-04-30	8.50%
2010-01-31	6.51%
2009-10-31	2.14%
2009-07-31	-1.80%
2009-04-30	-9.26%
2009-01-31	5.49%
2008-10-31	15.60%
2008-07-31	11.70%
2008-04-30	11.88%
2008-01-31	8.61%
2007-10-31	12.45%
2007-07-31	13.46%
2007-04-30	9.32%
2007-01-31	11.72%
2006-10-31	19.79%
2006-07-31	15.62%
2006-04-30	8.04%
2006-01-31	210.78%
2005-10-31	23.81%
2005-07-31	6.16%
2005-04-30	5.63%
2005-01-31	6.21%
2004-10-31	4.06%
2004-07-31	5.31%
2004-04-30	5.68%
2004-01-31	4.32%
2003-10-31	0.78%
2003-07-31	-103.60%
2003-04-30	-9.95%
2003-01-31	-26.13%
2002-10-31	-13.59%

DATE

NET PROFIT MARGIN

2026-07-31

19.28%

2026-04-30

18.47%

2026-01-31

16.96%

2025-10-31

23.32%

2025-07-31

19.33%

2025-04-30

12.89%

2025-01-31

18.92%

2024-10-31

20.63%

2024-07-31

17.87%

2024-04-30

19.58%

2024-01-31

20.99%

2023-10-31

28.14%

2023-07-31

6.64%

2023-04-30

17.59%

2023-01-31

20.05%

2022-10-31

19.90%

2022-07-31

19.15%

2022-04-30

17.05%

2022-01-31

16.91%

2021-10-31

26.63%

2021-07-31

16.65%

2021-04-30

14.16%

2021-01-31

18.60%

2020-10-31

14.97%

2020-07-31

15.78%

2020-04-30

8.16%

2020-01-31

14.52%

2019-10-31

14.19%

2019-07-31

14.99%

2019-04-30

14.70%

2019-01-31

39.25%

2018-10-31

15.07%

2018-07-31

19.62%

2018-04-30

17.00%

2018-01-31

-26.42%

2017-10-31

14.89%

2017-07-31

15.71%

2017-04-30

14.88%

2017-01-31

15.75%

2016-10-31

11.16%

2016-07-31

11.88%

2016-04-30

8.93%

2016-01-31

11.77%

2015-10-31

13.53%

2015-07-31

10.95%

2015-04-30

9.03%

2015-01-31

6.14%

2014-10-31

6.52%

2014-07-31

14.57%

2014-04-30

14.07%

2014-01-31

19.35%

2013-10-31

12.28%

2013-07-31

10.17%

2013-04-30

9.58%

2013-01-31

10.65%

2012-10-31

24.05%

2012-07-31

14.10%

2012-04-30

14.71%

2012-01-31

14.07%

2011-10-31

16.72%

2011-07-31

19.52%

2011-04-30

11.93%

2011-01-31

12.71%

2010-10-31

18.53%

2010-07-31

14.81%

2010-04-30

8.50%

2010-01-31

6.51%

2009-10-31

2.14%

2009-07-31

-1.80%

2009-04-30

-9.26%

2009-01-31

5.49%

2008-10-31

15.60%

2008-07-31

11.70%

2008-04-30

11.88%

2008-01-31

8.61%

2007-10-31

12.45%

2007-07-31

13.46%

2007-04-30

9.32%

2007-01-31

11.72%

2006-10-31

19.79%

2006-07-31

15.62%

2006-04-30

8.04%

2006-01-31

210.78%

2005-10-31

23.81%

2005-07-31

6.16%

2005-04-30

5.63%

2005-01-31

6.21%

2004-10-31

4.06%

2004-07-31

5.31%

2004-04-30

5.68%

2004-01-31

4.32%

2003-10-31

0.78%

2003-07-31

-103.60%

2003-04-30

-9.95%

2003-01-31

-26.13%

2002-10-31

-13.59%

Net Profit Margin: 19.53%

A Profit Margin

A Average Net Profit Margin Chart

A Current vs Average Net Profit Margin Chart

A Net Profit Margin Metrics

A Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

A Net Profit Margin History

Related Metrics